Akoya Biosciences, Inc. (AKYA) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
AKYA Insider Trading Activity
AKYA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $30,694 | 2 | 100 |
Related Transactions
| McKelligon Brian | President and CEO | 0 | $0 | 2 | $30,694 | $-30,694 |
About Akoya Biosciences, Inc.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Insider Activity of Akoya Biosciences, Inc.
Over the last 12 months, insiders at Akoya Biosciences, Inc. have bought $0 and sold $30,694 worth of Akoya Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Akoya Biosciences, Inc. have bought $6.53M and sold $679,875 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $92,014 was made by Pla Frederic (Chief Operating Officer) on 2023‑09‑07.
List of Insider Buy and Sell Transactions, Akoya Biosciences, Inc.
| 2024-06-11 | Sale | McKelligon Brian | President and CEO | 7,500 0.0145% | $2.08 | $15,630 | +7.76% | |
| 2024-06-06 | Sale | McKelligon Brian | President and CEO | 7,500 0.0146% | $2.01 | $15,064 | +12.68% | |
| 2024-03-20 | Sale | McKelligon Brian | President and CEO | 7,500 0.015% | $4.97 | $37,243 | -50.99% | |
| 2024-03-13 | Sale | McKelligon Brian | President and CEO | 7,500 0.0155% | $4.94 | $37,043 | -48.06% | |
| 2023-12-19 | Sale | McKelligon Brian | President and CEO | 7,500 0.0146% | $4.48 | $33,566 | -38.59% | |
| 2023-12-12 | Sale | McKelligon Brian | President and CEO | 7,500 0.0152% | $4.25 | $31,871 | -31.81% | |
| 2023-11-20 | Sale | McKelligon Brian | President and CEO | 7,500 0.0155% | $4.39 | $32,901 | -27.22% | |
| 2023-09-07 | Pla Frederic | Chief Operating Officer | 20,000 0.0412% | $4.60 | $92,014 | -9.47% | ||
| 2023-09-07 | Pla Frederic | Chief Operating Officer | 13,000 0.0268% | $4.60 | $59,814 | -9.47% | ||
| 2023-06-12 | Raffin Thomas A. | director | 2.02M 4.8443% | $5.00 | $10.1M | -13.79% | ||
| 2023-06-12 | Winkler Matthew | director | 203,388 0.4878% | $5.00 | $1.02M | -13.79% | ||
| 2023-06-12 | SHEPLER ROBERT G | director | 120,000 0.2878% | $5.00 | $600,000 | -13.79% | ||
| 2023-06-12 | Mendel Scott | director | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
| 2023-06-12 | LAI GOLDMAN MYLA | director | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
| 2023-06-12 | Ek John Frederick | CFO | 20,000 0.048% | $5.00 | $100,000 | -13.79% | ||
| 2023-06-06 | Sale | McKelligon Brian | President/CEO | 5,000 0.0131% | $5.71 | $28,537 | -17.02% | |
| 2023-03-14 | Sale | McKelligon Brian | President/CEO | 5,000 0.0135% | $9.17 | $45,852 | -39.07% | |
| 2022-12-14 | Sale | DRISCOLL JOSEPH | Chief Financial Officer | 14,574 0.0386% | $12.46 | $181,519 | -45.76% | |
| 2022-12-13 | Sale | SCHNETTLER THOMAS P | director | 71,050 0.1938% | $13.03 | $925,782 | -46.46% | |
| 2022-12-13 | Sale | Nolan Garry Ph.D. | director | 100 0.0003% | $13.25 | $1,325 | -46.46% |
Insider Historical Profitability
| McKelligon Brian | President and CEO | 224733 0.4506% | $212,530.00 | 0 | 12 | |
| Raffin Thomas A. | director | 15937535 31.9547% | $15.07M | 1 | 0 | <0.0001% |
| SCHNETTLER THOMAS P | director | 2742721 5.4991% | $2.59M | 0 | 1 | |
| Winkler Matthew | director | 984513 1.9739% | $931,053.94 | 1 | 0 | <0.0001% |
| Nolan Garry Ph.D. | director | 555084 1.1129% | $524,942.94 | 0 | 12 | |
| SHEPLER ROBERT G | director | 369592 0.741% | $349,523.15 | 2 | 0 | <0.0001% |
| Mendel Scott | director | 28500 0.0571% | $26,952.45 | 2 | 0 | <0.0001% |
| Ramachandran Niro Ph.D | Chief Business Officer | 25073 0.0503% | $23,711.54 | 2 | 0 | <0.0001% |
| LAI GOLDMAN MYLA | director | 20000 0.0401% | $18,914.00 | 1 | 0 | <0.0001% |
| Ek John Frederick | CFO | 20000 0.0401% | $18,914.00 | 1 | 0 | <0.0001% |
| Pla Frederic | Chief Operating Officer | 13000 0.0261% | $12,294.10 | 2 | 0 | <0.0001% |
| DRISCOLL JOSEPH | Chief Financial Officer | 12500 0.0251% | $11,821.25 | 0 | 1 |
AKYA Institutional Investors: Active Positions
| Increased Positions | 26 | +43.33% | 869,548 | +7.24% |
| Decreased Positions | 20 | -33.33% | 914,830 | -7.62% |
| New Positions | 7 | New | 555,931 | New |
| Sold Out Positions | 6 | Sold Out | 609,168 | Sold Out |
| Total Postitions | 66 | +10% | 12M | -0.38% |
AKYA Ownership Change vs Market
Institutional Investor Ownership
| Blue Water Life Science Advisors, Lp | $5,731.00 | 9.4% | 4.7M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $1,967.00 | 3.22% | 1.61M | -25,328 | -1.55% | 2025-03-31 |
| Vanguard Group Inc | $1,717.00 | 2.81% | 1.41M | -77,911 | -5.25% | 2024-12-31 |
| Paragon Associates & Paragon Associates Ii Joint Venture | $977.00 | 1.6% | 801,000 | +11,000 | +1.39% | 2024-12-31 |
| Geode Capital Management, Llc | $690.00 | 1.13% | 565,489 | +3,880 | +0.69% | 2024-12-31 |
| Svb Wealth Llc | $629.00 | 1.03% | 515,398 | +515,398 | New | 2024-12-31 |
| State Street Corp | $532.00 | 0.87% | 435,830 | -17,466 | -3.85% | 2024-12-31 |
| Northern Trust Corp | $305.00 | 0.5% | 250,343 | +39,799 | +18.9% | 2024-12-31 |
| Peddock Capital Advisors, Llc | $286.00 | 0.47% | 234,720 | 0 | 0% | 2025-03-31 |
| Gsa Capital Partners Llp | $220.00 | 0.36% | 180,734 | -129,935 | -41.82% | 2024-12-31 |